Total returns on £1000
1Y
- 3M
- 6M
- 1Y
- 3Y
- 5Y
| Fund/benchmark | Change | |
|---|---|---|
| Price | The Biotech Growth Trust PLC (Ordinary Share) | +46.89% |
| NAV | The Biotech Growth Trust PLC (Ordinary Share) | +43.36% |
| Morningstar's Benchmark | NASDAQ Biotechnology TR GBP | +32.53% |
Press releases
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Transaction in Own Shares
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Monthly Fact Sheet as at 31 January 2026
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Investor Presentation via Investor Meet Company
More ▼
Key statistics
As of last trade The Biotech Growth Trust PLC (BIOG:LSE) traded at 1,237.79, -4.79% below its 52-week high of 1,300.00, set on Jan 23, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Shares outstanding | 20.62m |
|---|---|
| Market cap | 252.65m GBP |
| Total assets | 307.55m GBP |
| Total expense ratio | -- |
| High | 1,250.00 |
| Low | 1,215.00 |
| Previous close | 1,245.00 |
| Average volume | 51.71k |
|---|---|
| YTD Change | +3.15% |
| Beta | 0.6292 |
| Diluted NAV (est) | 1,351.84 |
| Diluted NAV (last pub) | 1,315.71 |
| Premium/Discount | -8.21% |
| Net Gearing | +12.05% |
Data delayed at least 20 minutes, as of Feb 19 2026 15:20 GMT.
More ▼


